Trial Profile
Effects of Pioglitazone and Glimepiride in Hypertensive Patients - Relationship With AGE, Inflammatory Cytokines and Cardiac Markers.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Glimepiride
- Indications Insulin resistance
- Focus Pharmacodynamics; Therapeutic Use
- 04 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Nov 2011 New trial record